8-KThe WireRoutine
Bylaw Amendment
Filed Nov 18, 2024 · 1y ago · Accession 0001714899-24-000233
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Denali Therapeutics Inc.
- Ticker
- DNLI
- CIK
- 1714899
- Form type
- 8-K
- Filing date
- Nov 18, 2024
- Report date
- Nov 12, 2024
- Document
- dnli-20241112.htm
- Size
- 447 KB